Form 8-K - Current report:
SEC Accession No. 0001641172-25-025476
Filing Date
2025-08-26
Accepted
2025-08-26 09:29:47
Documents
12
Period of Report
2025-08-26
Items
Item 1.01: Entry into a Material Definitive Agreement

Document Format Files

Seq Description Document Type Size
1 8-K form8-k.htm   iXBRL 8-K 35450
  Complete submission text file 0001641172-25-025476.txt   202486

Data Files

Seq Description Document Type Size
2 XBRL SCHEMA FILE thar-20250826.xsd EX-101.SCH 3020
3 XBRL LABEL FILE thar-20250826_lab.xml EX-101.LAB 34239
4 XBRL PRESENTATION FILE thar-20250826_pre.xml EX-101.PRE 22362
14 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 3788
Mailing Address 245 MAIN STREET SUITE 204 CHESTER NJ 07930
Business Address 1200 ROUTE 22 EAST BRIDGEWATER NJ 08807 302-743-2995
Tharimmune, Inc. (Filer) CIK: 0001861657 (see all company filings)

EIN.: 842642541 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)